1. A Novel Endocrine Role for the BAT-Released Lipokine 12, 13-diHOME to Mediate Cardiac Function. Issue 2 (12th January 2021) Authors: Pinckard, Kelsey M.; Shettigar, Vikram K.; Wright, Katherine R.; Abay, Eaman; Baer, Lisa A.; Vidal, Pablo; Dewal, Revati S.; Das, Devleena; Duarte-Sanmiguel, Silvia; Hernández-Saavedra, Diego; Arts, Peter J.; Lehnig, Adam C.; Bussberg, Valerie; Narain, Niven R.; Kiebish, Michael A.; Yi, Fanchao; ... Journal: Circulation Issue: Volume 143:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes. Issue 4 (17th February 2016) Authors: Kovacova, Zuzana; Tharp, William G.; Liu, Dianxin; Wei, Wan; Xie, Hui; Collins, Sheila; Pratley, Richard E. Journal: Obesity Issue: Volume 24:Issue 4(2016) Page Start: 820 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An improvement in skeletal muscle mitochondrial capacity with short‐term aerobic training is associated with changes in Tribbles 1 expression. Issue 12 (19th June 2020) Authors: Vega, Rick B.; Brouwers, Bram; Parsons, Stephanie A.; Stephens, Natalie A.; Pino, Maria F.; Hodges, Andrew; Yi, Fanchao; Yu, Gongxin; Pratley, Richard E.; Smith, Steven R.; Sparks, Lauren M. Journal: Physiological reports Issue: Volume 8:Issue 12(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg. Issue 11 (9th August 2021) Authors: Pratley, Richard E.; Catarig, Andrei‐Mircea; Lingvay, Ildiko; Viljoen, Adie; Paine, Abby; Lawson, Jack; Chubb, Barrie; Gorst‐Rasmussen, Anders; Miresashvili, Nino Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 11(2021) Page Start: 2513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Assessing the Pathophysiology of Hyperglycemia in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium. Issue 6 (July 2022) Authors: Dungan, Kathleen M.; Hart, Phil A.; Andersen, Dana K.; Basina, Marina; Chinchilli, Vernon M.; Danielson, Kirstie K.; Evans-Molina, Carmella; Goodarzi, Mark O.; Greenbaum, Carla J.; Kalyani, Rita R.; Laughlin, Maren R.; Pichardo-Lowden, Ariana; Pratley, Richard E.; Serrano, Jose; Sims, Emily K.; S... Journal: Pancreas Issue: Volume 51:Issue 6(2022) Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Basal insulin peglispro increases lipid oxidation, metabolic flexibility, thermogenesis and ketone bodies compared to insulin glargine in subjects with type 1 diabetes mellitus. Issue 5 (4th February 2018) Authors: Porksen, Niels K.; Linnebjerg, Helle; Lam, Eric Chen Quin; Garhyan, Parag; Pachori, Alok; Pratley, Richard E.; Smith, Steven R. Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 5(2018) Page Start: 1193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Body weight loss with oral semaglutide is mediated predominantly by effects other than gastrointestinal adverse events in patients with type 2 diabetes: A post hoc analysis. Issue 4 (17th January 2023) Authors: Meier, Juris J.; Bardtrum, Lars; Cheng, Alice Y. Y.; Malling, Brian; Montanya, Eduard; Wagner, Lily; Pratley, Richard E. Journal: Diabetes, obesity & metabolism Issue: Volume 25:Issue 4(2023) Page Start: 1130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study. Issue 11 (13th August 2019) Authors: Pratley, Richard E.; Kang, Jahoon; Trautmann, Michael E.; Hompesch, Marcus; Han, OakPil; Stewart, John; Sorli, Christopher H.; Jacob, Stephan; Yoon, Kun‐Ho Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 11(2019) Page Start: 2429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium‐glucose cotransporter‐2 inhibitor ertugliflozin. Issue 3 (26th December 2022) Authors: Corbin, Karen D.; Dagogo‐Jack, Samuel; Cannon, Christopher P.; Cherney, David Z.I.; Cosentino, Francesco; Frederich, Robert; Liu, Jie; Pong, Annpey; Lin, Jianxin; Cater, Nilo B.; Pratley, Richard E. Journal: Diabetes, obesity & metabolism Issue: Volume 25:Issue 3(2023) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV. Issue 7 (29th March 2022) Authors: Dagogo‐Jack, Samuel; Cannon, Christopher P.; Cherney, David Z. I.; Cosentino, Francesco; Liu, Jie; Pong, Annpey; Gantz, Ira; Frederich, Robert; Mancuso, James P.; Pratley, Richard E. Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 7(2022) Page Start: 1245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗